YPrime’s IRT—
Certainty in Clinical Trial Randomization and Supply Chain Management 

Clinical trials are integral to unlocking life-saving treatments. But with 60% of trials experiencing delays and 56% dealing with four+ protocol amendments, you can’t afford sub-standard Interactive Response Technology (IRT).

A pharmaceutical company recently approached YPrime with a significant hurdle. Their existing IRT platform took over six weeks for each (of the eight!) protocol amendments during their clinical trial, resulting in a staggering 48+ weeks of trial delays. Clearly, an unacceptable situation.

YPrime’s IRT has a proven history of de-risking clinical trials. With 50% faster study start-up times, 4x faster system changes related to protocol amendments, and a 100% configurable platform, we can help you solve for certainty.

Download our latest fact sheet and learn more about how YPrime’s IRT technology platform can help you improve your clinical trials.

Scroll to Top